Press Release
June 7, 2022

Holland & Knight Advises SkyKnight Capital on Investment in DOCS Dermatology

SAN FRANCISCO (June 7, 2022) – Holland & Knight represented SkyKnight Capital, a San Francisco-based private equity firm, on its purchase of a stake in DOCS Dermatology, one of the largest dermatology management platforms in the U.S., from Sheridan Capital Partners. The deal was announced on June 1.

Headquartered in Cincinnati, Ohio, DOCS has over 80 clinics and more than 1,300 employees. The company’s highly experienced, board-certified dermatologists, surgeons, nurse practitioners and physician assistants provide comprehensive patient care covering general dermatology, surgical, pathology and cosmetic services.

Founded in 2015, SkyKnight Capital manages $2.5 billion in private equity capital on behalf of leading institutional family offices, foundations, endowments and pensions. SkyKnight makes long-term investments into high-quality businesses in acyclical growth sectors alongside exceptional management teams. SkyKnight aims to build industry-defining businesses in healthcare, financial services and tech-enabled services.

Holland & Knight Partners Aaron Slavens and Jordan Schneider and Associates Kyle Gaughan and Gabrielle Engel led the firm’s representation of SkyKnight Capital. They were assisted by Partners Jeffrey Mittleman, William Sherman, Eric Rubin and David Valeck and Associates Anna Kozlowski, Dan Janovitz,  Josh Pelfrey, Michael Romeo and Jiyeon Barta.

More information about the transaction can be found here.

Holland & Knight's corporate practice is ranked as a national first-tier firm in Leveraged Buyouts and Private Equity Law, Corporate Law and M&A Law in the 2022 U.S. News – Best Lawyers "Best Law Firms" guide. The firm is consistently ranked among the Top 25 law firms in the nation advising on U.S. M&A transactions by deal count in Refinitiv and other league tables. Through the HK Deal Flow® program, Holland & Knight facilitates deal leads for clients and prospective clients by matching acquisition or capital raising opportunities with buyers and investors.

Related News and Headlines